Lunt Capital Management, Inc.
Source: SEC Form 13F · as of Mar 2026Lunt Capital Management, Inc. holds 1 biotech & pharma company tracked by BioSniper, totaling $258K in value as of Mar 2026 (SEC Form 13F).
Companies held
1
Total value held
$258K
BioSniper AIPage evidence connected
Prepared research question
What matters most for Clene Inc. (CLNN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| CLNNClene Inc. | 52,260 | $258K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.